Clinical Trial Update: Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial evaluated stem cell transplantation with or without Rituximab in patients with relapsed or progressive Diffuse Large B-Cell Lymphoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Lymphoma | Phase 3 | Status: COMPLETED